SCHEMBL7083369

SCHEMBL7083369

CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1ccccc1Oc1ccsc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.43
MTNR1B P49286 2/20 0.40
L3MBTL1 Q9Y468 5/20 0.39
MAPT P10636 3/20 0.39
MAPK1 P28482 2/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSD17B10 Q99714 2/20 0.39
NPSR1 Q6W5P4 2/20 0.38
POLB P06746 1/20 0.38
ATM Q13315 1/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
F2R P25116 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HTT P42858 1/20 0.37
MRGPRX1 Q96LB2 1/20 0.37
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7077440 0.86 MAPT (0.41) L3MBTL1MAPTMAPK1GAATDP1
SCHEMBL7076729 0.83 MTNR1B (0.45) RAB9AMTNR1BL3MBTL1MAPTHSD17B10
SCHEMBL7080643 0.83 RAB9A (0.43) RAB9AMTNR1BL3MBTL1MAPTMAPK1
SCHEMBL7080256 0.82 HSD17B10 (0.50) RAB9AMTNR1BL3MBTL1MAPTMAPK1
SCHEMBL7083339 0.77 CAPN1 (0.46) RAB9AMAPTMAPK1GAAMEN1
SCHEMBL7081568 0.75 PTK2 (0.41) L3MBTL1MAPTMAPK1GAATDP1
SCHEMBL7080331 0.74 SGMS2 (0.52) MEN1KMT2A
SCHEMBL7076725 0.74 MTNR1B (0.48) RAB9AMTNR1BNPSR1LMNAMEN1
SCHEMBL7744231 0.73 CASP1 (0.51) MTNR1BL3MBTL1NPSR1POLBATM
SCHEMBL7080300 0.72 ALDH1A1 (0.48) RAB9AMTNR1BLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN RAB9A 3579/4885MTNR1B 980/4885L3MBTL1 1305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.